Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1983 1
1996 2
1999 3
2000 4
2001 1
2002 3
2003 8
2004 2
2005 4
2006 7
2007 5
2008 1
2009 7
2010 8
2011 6
2012 6
2013 12
2014 9
2015 6
2016 11
2017 9
2018 4
2019 5
2020 12
2021 11
2022 11
2023 5
2024 11
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocol.
Budillon A, Leone A, Passaro E, Silvestro L, Foschini F, Iannelli F, Roca MS, Macchini M, Bruzzese F, Garcia Bermejo ML, Rodriguez Garrote M, Tortora G, Milella M, Reni M, Fuchs C, Hewitt E, Kubiak C, Di Gennaro E, Giannarelli D, Avallone A. Budillon A, et al. Among authors: di gennaro e. BMC Cancer. 2024 Sep 19;24(1):1167. doi: 10.1186/s12885-024-12936-w. BMC Cancer. 2024. PMID: 39300376 Free PMC article.
Integrated proteomics and metabolomics analyses reveal new insights into the antitumor effects of valproic acid plus simvastatin combination in a prostate cancer xenograft model associated with downmodulation of YAP/TAZ signaling.
Iannelli F, Lombardi R, Costantini S, Roca MS, Addi L, Bruzzese F, Di Gennaro E, Budillon A, Pucci B. Iannelli F, et al. Among authors: di gennaro e. Cancer Cell Int. 2024 Nov 16;24(1):381. doi: 10.1186/s12935-024-03573-1. Cancer Cell Int. 2024. PMID: 39550583 Free PMC article.
The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers.
Mottini C, Auciello FR, Manni I, Pilarsky C, Caputo D, Caracciolo G, Rossetta A, Di Gennaro E, Budillon A, Blandino G, Roca MS, Piaggio G. Mottini C, et al. Among authors: di gennaro e. J Exp Clin Cancer Res. 2024 Jul 18;43(1):198. doi: 10.1186/s13046-024-03117-5. J Exp Clin Cancer Res. 2024. PMID: 39020414 Free PMC article. Review.
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.
Costantini S, Madonna G, Capone M, Di Gennaro E, Bagnara P, Renza F, Mallardo D, Affatato R, Vitagliano C, Romanelli M, Tuffanelli M, Simeone E, Ciliberto G, Ascierto PA, Budillon A. Costantini S, et al. Among authors: di gennaro e. J Exp Clin Cancer Res. 2025 Apr 10;44(1):119. doi: 10.1186/s13046-025-03378-8. J Exp Clin Cancer Res. 2025. PMID: 40211360 Free PMC article.
164 results